Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
NCT06450106
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
STM-416p
Sponsor
SURGE Therapeutics